| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Igor M Belyakov | |
| Jeffrey D Ahlers | |||
| P2860 | cites work | DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | 6883-6892 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? | |
| P478 | volume | 183 |
| Q56787248 | A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge |
| Q47897645 | A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever |
| Q37547653 | A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2. |
| Q30384745 | Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines. |
| Q43519933 | Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage. |
| Q35042602 | Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses |
| Q64115375 | Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves |
| Q33784457 | Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system |
| Q91832425 | An intramembrane sensory circuit monitors sortase A-mediated processing of streptococcal adhesins |
| Q37015487 | Antibodies and their receptors: different potential roles in mucosal defense. |
| Q47288431 | Applications of chemokines as adjuvants for vaccine immunotherapy |
| Q98157721 | Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency |
| Q35155933 | Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics |
| Q84004437 | Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration |
| Q38794720 | Brucellosis vaccines for livestock |
| Q36459120 | CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose |
| Q40085228 | CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine-Induced T Cells to Both the Lung Parenchyma and Airway. |
| Q36002296 | Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes |
| Q37324787 | Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes |
| Q39259629 | Current state and challenges in developing oral vaccines |
| Q35758746 | DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection |
| Q35099609 | Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection |
| Q43514266 | Differentially imprinted innate immunity by mucosal boost vaccination determines antituberculosis immune protective outcomes, independent of T-cell immunity. |
| Q37627725 | Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. |
| Q47359574 | Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex |
| Q40513167 | Eliciting Epitope-Specific CD8+ T Cell Response by Immunization with Microbial Protein Antigens Formulated with α-Galactosylceramide: Theory, Practice, and Protocols |
| Q45325097 | Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1. |
| Q37154783 | Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency |
| Q35076903 | Environmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytes |
| Q92175839 | Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host |
| Q34920723 | Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies |
| Q42258701 | Evaluation of virus-specific cellular immune response in transplant patients. |
| Q42222484 | Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza |
| Q42253366 | Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route |
| Q50040757 | Flagellin produced in plants is a potent adjuvant for oral immunization |
| Q91986433 | Formulation technologies for oral vaccines |
| Q38140036 | Future directions for the development of Chlamydomonas-based vaccines |
| Q37950928 | GUCY2C-targeted cancer immunotherapy: past, present and future. |
| Q40351285 | Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model |
| Q26822643 | Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells |
| Q34422068 | Human cytomegalovirus tropism for mucosal myeloid dendritic cells |
| Q37812125 | Human influenza vaccines and assessment of immunogenicity |
| Q40731935 | Identification of Immune Effectors Essential to the Control of Primary and Secondary Intranasal Infection with Brucella melitensis in Mice. |
| Q35530236 | Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium |
| Q90482717 | Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing Escherichia coli |
| Q36715877 | Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors |
| Q37067286 | Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin |
| Q98952103 | Immunological considerations for COVID-19 vaccine strategies |
| Q38544598 | Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q40214060 | In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4(+) T cell responses protecting from airway challenge with recombinant vaccinia-gag virus |
| Q64379651 | Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease |
| Q39436774 | Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands |
| Q38374165 | Induction of protection in murine experimental models against Trichinella spiralis: an up-to-date review |
| Q36159388 | Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin |
| Q37774770 | Interleukin-12 as an adjuvant for induction of protective antibody responses. |
| Q36735275 | Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract. |
| Q40695948 | Intranasal Vaccination With Salmonella-Derived Serodominant Secreted Effector Protein B Associated With Gas-Filled Microbubbles Partially Protects Against Gut Infection in Mice |
| Q28482083 | Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice |
| Q30360875 | Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets. |
| Q40096268 | Intrauterine delivery of subunit vaccines induces a systemic and mucosal immune response in rabbits. |
| Q50991984 | Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells. |
| Q34565122 | Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro |
| Q64067951 | Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis |
| Q50960529 | Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. |
| Q34060493 | Memories that last forever: strategies for optimizing vaccine T-cell memory |
| Q40107089 | Microneedles: quick and easy delivery methods of vaccines. |
| Q34653879 | Molecular basis of live-attenuated influenza virus |
| Q37782497 | Molecular pathways regulating CD4+ T cell differentiation, anergy and memory with implications for vaccines |
| Q22241377 | Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes |
| Q34291997 | Mucosal T cells in gut homeostasis and inflammation |
| Q64085586 | Mucosal immune responses induced by oral administration recombinant expressing the COE antigen of PEDV in newborn piglets |
| Q36517179 | Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity |
| Q33862822 | Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors |
| Q54298445 | Mucosal vaccination shapes the expression of salivary antibodies and establishment of CD8+ T-cells. |
| Q58587624 | Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q84340924 | Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes |
| Q42284364 | Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model |
| Q28536886 | Near-infrared laser adjuvant for influenza vaccine |
| Q37833756 | Neutrophils are Central to Antibody-Mediated Protection against Genital Chlamydia |
| Q95267822 | New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes |
| Q37384717 | New generation of dendritic cell vaccines |
| Q28392109 | Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge |
| Q36907013 | Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB. |
| Q38168900 | Novel approaches in polyepitope T-cell vaccine development against HIV-1. |
| Q41335764 | Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection |
| Q40491174 | Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy |
| Q37948126 | OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses |
| Q91862911 | Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen |
| Q27313927 | Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis |
| Q53076908 | PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. |
| Q39664804 | PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine |
| Q36973944 | Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses |
| Q51495627 | Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors. |
| Q38265356 | Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development |
| Q26825847 | Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects |
| Q27024526 | Prime-boost approaches to tuberculosis vaccine development |
| Q36941335 | Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli |
| Q92999727 | Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques |
| Q40098642 | Quantum dot/pMHC multimers vs. phycoerythrin/pMHC tetramers for identification of HLA-A*0201-restricted pHBV core antigen18-27-specific T cells |
| Q62487341 | Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1 |
| Q40228907 | Recent developments in nanocarrier-aided mucosal vaccination |
| Q38029250 | Recent progress in mucosal vaccine development: potential and limitations |
| Q38068954 | Recent progress towards development of a Shigella vaccine |
| Q45325594 | Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection |
| Q35535516 | Resistance to Toxoplasma gondii infection in mice treated with silk protein by enhanced immune responses |
| Q37694873 | Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. |
| Q33755761 | Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model |
| Q90147842 | Selection of adjuvants for vaccines targeting specific pathogens |
| Q40273775 | Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice |
| Q27318575 | Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses |
| Q89138019 | Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant |
| Q40566186 | Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection |
| Q35193006 | Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection |
| Q36339059 | Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88. |
| Q24635244 | The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice |
| Q38650844 | The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. |
| Q90055110 | The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice |
| Q49933333 | The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses. |
| Q34425648 | Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies |
| Q36038449 | What is the influence of vaccination's routes on the regression of tumors located at mucosal sites? |
Search more.